ArticleBMC gastroenterology2022

Efficacy and safety of glecaprevir and pibrentasvir in Japanese patients with hepatitis C virus infection aged 75 years or older.

Yuri Komaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.